Replimune (REPL) Other Non-Current Assets (2018 - 2025)

Replimune's (REPL) quarterly Other Non-Current Assets came in at $1.7 million in Q4 2025, up 42.0% year-on-year from $1.2 million in Q4 2024, and up 42.0% quarter-over-quarter from $1.2 million in Q3 2025.

Replimune (REPL) Other Non-Current Assets (2018 - 2025) Analysis & Trends

Replimune has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $1.7 million for Q4 2025.

  • Other Non-Current Assets for Q4 2025 came in at $1.7 million, up 42.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 million (up 42.0% YoY), and the FY2025 annual result was $1.2 million, changed N/A from the prior year.
  • Other Non-Current Assets came in at $1.7 million for Q4 2025 at Replimune, up from $1.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q3 2024 to a low of $1.2 million in Q4 2024.
  • The 5-year median for Other Non-Current Assets is $1.6 million (2021), against an average of $1.6 million.
  • Peak annual rise in Other Non-Current Assets reached 42.0% in 2025, while the deepest fall reached 29.62% in 2025.
  • Replimune's Other Non-Current Assets stood at $1.6 million in 2021, then changed by 0.0% to $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then declined by 26.65% to $1.2 million in 2024, then soared by 42.0% to $1.7 million in 2025.
  • The last three Other Non-Current Assets figures came in at $1.7 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Replimune 780.01 Mn 510.88 Mn - 1.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.70 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 1.20 Mn
Sep 30, 2024 1.71 Mn
Jun 30, 2024 1.70 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 1.64 Mn
Mar 31, 2023 1.64 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 1.64 Mn
Jun 30, 2022 1.64 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 1.64 Mn
Jun 30, 2021 1.64 Mn
Mar 31, 2021 1.64 Mn
Dec 31, 2020 1.64 Mn